Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Comparison with Standard Treatments Studies comparing BPC-157 to becaplermin (the active ingredient in Regranex, an FDA-approved treatment for diabetic foot ulcers) found BPC-157 produced superior results in several parameters
Researchers modelling the OASIS 1 or REDEFINE titration curves will typically draw 824 study doses from a single 12mg pen [6]
Current research and clinical experience suggest that regenerative therapies like PRP and exosome injections have a strong safety profile
This difference in mechanism is what makes the combination potentially valuable
Journal of Physiology-Paris, 87(5), 313327
Preclinical Research Findings In animal models, including diabetic and ischemic wound studies, GHK-Cu has been associated with: Faster wound contraction and improved healing rates (64.5% reduction in wound size vs
US$ 29.73
US$ 29.10
US$ 20.38
US$ 23.58
